Contralateral psoas seroma after transpsoas lumbar interbody fusion with bone morphogenetic protein-2 implantation

Spine Journal

Volumn 13, Issue 2, 2013, Pages e1-

  Taher, Fadi ^a   Lebl, Darren R ^a   Hughes, Alexander P ^a   Girardi, Federico P ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

BMP; Complications; Lateral lumbar interbody fusion; Psoas seroma; XLIF

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADULT; ARTICLE; CASE REPORT; CONTRALATERAL PSOAS MUSCLE SEROMA; DISEASE SEVERITY; ELECTROMYOGRAPHY; FEMALE; FLUOROSCOPY; FOLLOW UP; HUMAN; LEG PAIN; MEDLINE; MUSCLE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATION DURATION; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSOAS MUSCLE; SCOLIOSIS; SEROMA; SPINE FUSION; SPINE RADIOGRAPHY; TRANSPSOAS LUMBAR INTERBODY FUSION; VERTEBRAL CANAL STENOSIS;

EID: 84875247271     PISSN: 15299430     EISSN: 18781632     Source Type: Journal    
DOI: 10.1016/j.spinee.2012.11.052     Document Type: Article

References (25)

1. W.B. Rodgers, E.J. Gerber, and J. Patterson Intraoperative and early postoperative complications in extreme lateral interbody fusion: an analysis of 600 cases Spine 36 2011 26 32
2. G.A. Fantini, I.P. Pappou, and F.P. Girardi Major vascular injury during anterior lumbar spinal surgery: incidence, risk factors, and management Spine 32 2007 2751 2758
3. V. Rajaraman, R. Vingan, and P. Roth Visceral and vascular complications resulting from anterior lumbar interbody fusion J Neurosurg 91 1 Suppl 1999 60 64
4. B.M. Ozgur, H.E. Aryan, L. Pimenta, and W.R. Taylor Extreme lateral interbody fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion Spine J 6 2006 435 443
5. M. Pumberger, A.P. Hughes, and R.R. Huang Neurologic deficit following lateral lumbar interbody fusion Eur Spine J 21 2012 1192 1199
6. I.D. Papanastassiou, M. Eleraky, and F.D. Vrionis Contralateral femoral nerve compression: an unrecognized complication after extreme lateral interbody fusion (XLIF) J Clin Neurosci 18 2011 149 151
7. R.E. Isaacs, J. Hyde, and J.A. Goodrich A prospective, nonrandomized, multicenter evaluation of extreme lateral interbody fusion for the treatment of adult degenerative scoliosis: perioperative outcomes and complications Spine 35 26 Suppl 2010 S322 S330
8. R.D. Muchow, W.K. Hsu, and P.A. Anderson Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion Spine J 10 2010 e1 e6
9. R.S. Brower, and N.M. Vickroy A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5 Spine 33 2008 E653 E655
10. J.K. Burkus, M.F. Gornet, C.A. Dickman, and T.A. Zdeblick Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages J Spinal Disord Tech 15 2002 337 349
11. S.D. Glassman, L.Y. Carreon, and M. Djurasovic RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age Spine 33 2008 2843 2849
12. M. Boakye, P.V. Mummaneni, and M. Garrett Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein J Neurosurg Spine 2 2005 521 525
13. S.D. Glassman, J. Howard, and J. Dimar Complications with recombinant human bone morphogenic protein-2 in posterolateral spine fusion: a consecutive series of 1037 cases Spine 36 2011 1849 1854
14. D.A. Wong, A. Kumar, and S. Jatana Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2) Spine J 8 2008 1011 1018
15. J.A. Rihn, R. Patel, and J. Makda Complications associated with single-level transforaminal lumbar interbody fusion Spine J 9 2009 623 629
16. N.F. Chen, Z.A. Smith, and E. Stiner Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion J Neurosurg Spine 12 2010 40 46
17. E.J. Carragee, K.A. Mitsunaga, E.L. Hurwitz, and G.J. Scuderi Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study Spine J 11 2011 511 516
18. E.J. Carragee, E.L. Hurwitz, and B.K. Weiner A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned Spine J 11 2011 471 491
19. T.E. Mroz, J.C. Wang, R. Hashimoto, and D.C. Norvell Complications related to osteobiologics use in spine surgery: a systematic review Spine 35 9 Suppl 2010 S86 S104
20. S.D. Glassman, J.M. Howard, A. Sweet, and L.Y. Carreon Complications and concerns with osteobiologics for spine fusion in clinical practice Spine 35 2010 1621 1628
21. R.W. Haid Jr., C.L. Branch Jr., J.T. Alexander, and J.K. Burkus Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages Spine J 4 2004 527 538 discussion 538-9
22. R.J. Mannion, A.M. Nowitzke, and M.J. Wood Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2 - but what is the cost? Spine J 11 2011 527 533
23. B. Perri, M. Cooper, C. Lauryssen, and N. Anand Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study Spine J 7 2007 235 239
24. J.D. Smucker, J.M. Rhee, and K. Singh Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine Spine 31 2006 2813 2819
25. Center for Devices and Radiological Health. FDA public health notification: life-threatening complications associated with recombinant human bone morphogenetic protein in cervical spine fusion; updated 12/02/2010. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ PublicHealthNotifications/ucm062000.htm. Accessed November 17, 2011.